National Academy of Medicine

Advisory Group for Human Gene Editing Initiative Named

June 15, 2015

The NAS and the NAM have formed an advisory group for the academies’ joint Initiative on Human Gene Editing. The role of the advisory group will be to identify and gather information and advice from the scientific and medical communities that will enable the academies to guide and inform researchers, clinicians, policy makers, and the public.

David Baltimore1,2
President Emeritus and Robert Andrews Millikan Professor of Biology
California Institute of Technology

Paul Berg1,2
Robert W. and Vivian K. Cahill Professor Emeritus and Director Emeritus
Beckman Center for Molecular and Genetic Medicine
Stanford University School of Medicine
Stanford, Calif.

Alta Charo2
Warren P. Knowles Professor of Law and Bioethics
School of Law, and
Department of Medical History and Bioethics
School of Medicine and Public Health
University of Wisconsin

Jennifer A. Doudna1,2
Howard Hughes Medical Institute; and
Department of Molecular and Cell Biology, Lawrence Berkeley National Laboratory, and Department of Chemistry
University of California

Diane E. Griffin1,2
University Distinguished Service Professor
Harry Feinstone Department of Molecular Microbiology and Immunology
Bloomberg School of Public Health
Johns Hopkins University

Richard O. Hynes1,2
Howard Hughes Medical Institute; and
Daniel K. Ludwig Professor for Cancer Research
Koch Institute for Integrative Cancer Research
Massachusetts Institute of Technology

Peter S. Kim1,2
Virginia & D.K. Ludwig Professor of Biochemistry
Stanford ChEM-H
Department of Biochemistry
Stanford University School of Medicine
Stanford, Calif.

Robin Lovell-Badge
Group Leader and Head
Division of Stem Cell Biology and Developmental Genetics
The Francis Crick Institute
London, United Kingdom

Edward E. Penhoet2
Associate Dean of Biology
University of California, Berkeley; and
Alta Partners
San Francisco

Maxine F. Singer1,2
President Emerita
Carnegie Institution for Science
Washington, D.C.

Marc T. Tessier-Lavigne1,2
President, and
Carson Family Professor
Laboratory of Brain Development and Repair
The Rockefeller University
New York City

Nancy S. Wexler2
Hereditary Disease Foundation; and
Higgins Professor of Neuropsychology
College of Physicians and Surgeons
Columbia University
New York City

Keith R. Yamamoto1,2
Vice Chancellor for Research,
Executive Vice Dean, and
Department of Cellular and Molecular Pharmacology
School of Medicine
University of California
San Francisco

Xu Zhihong
School of Life Sciences
Peking University, and
Committee for Scientific Morality and Ethics, Academic Divisions
Chinese Academy of Sciences
Beijing, China

1 – Member, NAS
2 – Member, NAM